CURRENT ISSUES IN DIAGNOSING THE RESPIRATORY MANIFESTATION OF GASTROESOPHAGEAL REFLUX DISEASE

Authors:

Abstract:

The purpose of the study was to determine the leading extraesophageal symptoms, disturbance of spirometric indices, changes in the immune system and production of nitric oxide in patients with gastroesophageal reflux disease. Bronchopulmonary manifestation of gastroesophageal reflux disease was a cough syndrome, which was characterized by the presence of non-intensive, unproductive cough with a small amount of mucous sputum and was combined, in most cases, with the hoarseness of the voice. Cough syndrome during gastroesophageal reflux disease was characterized by a lack of obstructive changes in the study of external respiration indices and elevated levels of proinflammatory cytokines in the blood serum. It was determined the higher nitric oxide content in platelets in patients with respiratory manifestations of gastroesophageal reflux disease.

Keywords:

gastroesophageal reflux disease cough syndrome proinflammatory cytokines chronic obstructive pulmonary disease

References:

1. Boyko TV. Suchasni aspecty diahnostyky khvoroby hastroezofahealnoho reflyuksu (ohlyad literatury). Dosyahnennya klinichnoyi ta eksperymentalnoyi medytsyny. 2017; 2:8−12. [in Ukrainian]
2. Nakaz N 555 MOZ Ukrayiny vid 27.06.2013r. Pro zatverdzhennya ta vprovadzhennya medyko-tekhnolohichnykh dokumentiv zi standartyzatsiyi medychnoyi dopomohy pry khronichnomu obstruktyvnomu zakhvoryuvanni lehen. Dostupno na: http://www.moz.gov.ua/ua/portal/dn_20130627_0555.html. [in Ukrainian]
3. Osyodlo HV, Radushynska MV, Huryanov VH. Kompleksna terapiya hastroezofahealnoyi reflyuksnoyi khvoroby u poyednanni iz tryvozhno-depresyvnymy stanamy v uchasnykiv antyterorystychnoyi operatsiyi. Hastroenterol.2018; 52(2):14−20. [in Ukrainian]
4. Pikas OB. Osoblyvosti diyi oksydu azotu ta yoho metabolitiv v orhanizmi lyudyny, yikh znachennya u vynyknenni patolohichnykh protsesiv.Visnyk problem biolohfyi i medytsyny. 2015; 3;1 (22):28−33. [in Ukrainian]
5. Pochynok TV, Zhuravel OV, Chernov OV. Vmist oksydu azotu ta yoho metabolitiv u krovi ta slyzoviy stravokhodu u ditey z chastymy respiratornymy zakhvoryuvannyamy na tli hastroezofahealnoyi reflyuksnoyi khvoroby. Sovremennaya pediatriya. 2019; 2(98):31−4. [in Ukrainian]
6. Suvorkyna YV. Éffektyvnost primeneniya fenspirida (érespala) v lechenii bolnykh khronycheskim obstruktivnym zabolevaniyem legkikh tyazhelogo techeniya. Ukrayinskyy pulmonolohichnyy zhurnal. 2005; 3:28−31. [in Russian]
7. Treumova SI. Rol oksydu azotu, prostatsyklinu v patohenezi bronkholehenevoyi ta senrtsevo-sudynnoyi patolohiyi (ohlyad literatury).Visnyk problem biolohiyi i medytsyny. 2013; 3;2 (103):45−50. [in Ukrainian]
8. Unifikovanyy klinichnyy protokol pervynnoyi medychnoyi dopomohy «Kashel u doroslykh». Nakaz MOZ Ukrayiny vid 8 chervnya 2015 roku N 327. Klinichna imunolohiya, alerholohiya, infektolohiya. 2016;3:38−5. [in Ukrainian]
9. Unifikovanyy klinichnyy protokol pervynnoyi (vtorynnoyi) spetsializovanoyi medychnoyi dopomohy «Hastroezofahealna reflyuksna khvoroba». Nakaz Ministerstva okhorony zdorovya Ukrayiny vid 31 zhovtnya 2013 roku N 943 //http://www.moz.gov.ua/ua/portal/dn_20131031_0943.html. [in Ukrainian]
10. Khimion LV, Yashchenko OB. Efektyvne i bezpechne likuvannya sukhoho kashlyu – aktualna problema zahalnolikarskoyi praktyky. Simeyna medytsyna. 2015;1:130−3. [in Ukrainian]
11. Bychkova S. Role of interleukin-17 in disease course of different phenotypes of chronic obstructive pulmonary disease. Pharma Innovation Jour. 2017; 6(8):264−7.
12. De Bortoli N, Martinucci I, Bertani I. Esophageal testing; what we have so far. World Journal Gastrointest. Pathophysiol. 2016; 7(1):71−9.
13. Hunt R, Armstrong D, Katelaris P. Global perspective on gastroesophageal reflux disease [Electronic resource]. Global World Gastroenterojogy Organisation Global Guidelines. 2015; URL:http //www Guidelines Global Guidelines/ summaries /summary / 37564.12.
14. Isomoto H, Inoue K, Kohno S. Interleukin-8 levels in esophageal mucosa and long-term clinical outcome of patients with reflux esophagitis. Scandinavian Journal of Gastroenterol. 2007; 42:410−6.
15. Lok HC, Sahni S, Jansson PJ. A nitric oxide storage and transport system that protects activated macrophages from endogenous nitric oxide cytotoxicity. Journal of Biological Chemistry. 2016; 291(53):27042–61.

Publication:

«World of Medicine and Biology» Vol. 17 No. 75 (2021) , с. 119-124
УДК 616.24:616.329.-002-071

DOI:

https://doi.org/10.26724/2079-8334-2021-1-75-119-124